Search
for
Sort by
Research 871–900 of 1000+
- Metabolic, Behavioral, and Reproductive Effects of Vertical Sleeve Gastrectomy in an Obese Rat Model of Polycystic Ovary Syndrome
- Update on the therapeutic role of metformin in the management of polycystic ovary syndrome: Effects on pathophysiologic process and fertility outcomes
- Polycystic ovary syndrome: a common reproductive syndrome with long-term metabolic consequences
- An update of polycystic ovary syndrome: causes and therapeutics options
- Validation of the follicular and ovarian thresholds by an 18-MHz ultrasound imaging in polycystic ovary syndrome: a pilot cutoff for North African patients
- Effects of orlistat on serum androgen levels among iranian obese women with polycystic ovarian syndrome
- The Hidden Link between Polycystic Ovary Syndrome and Kidney Stones: Finding from the Tehran Lipid and Glucose Study (TLGS)
- Time Perspective as a Mediator of Depressive Symptoms in Patients with Polycystic Ovary Syndrome
- Prevalence, Symptomatology and Herbal Management of Polycystic Ovarian Syndrome
- Use of Myoinositol in PCOS
- Dietary Patterns and Metabolic and Hormonal Parameters in Women with Suspected PCOS
- Pattern of body fat distribution in patients of PCOS using DEXA-based indices
- Genetic Association Between Polycystic Ovary Syndrome and the <i>APOA5</i> rs662799 and <i>PLIN1</i> rs894160 Metabolic Variants in the Western Saudi Population: A Case-Control Study
- Maternal androgen excess significantly impairs sexual behavior in male and female mouse offspring: Perspective for a biological origin of sexual dysfunction in PCOS
- Women With Polycystic Ovary Syndrome: A Review of Susceptibility to Type 2 Diabetes
- The Association Between Polycystic Ovary Syndrome and Its Dermatological Manifestations
- Defective Expression of the Gap Junction Protein Pannexin-1 Channel Contributes to the Formation of PCOS-Realted Androgenetic Alopecia
- Activity of 17β-(N-Alkyl/arylformamido) and 17β-[(N-Alkyl/aryl) alkyl/arylamido]-4-methyl-4-aza-5α-androstan-3-ones as 5α-Reductase Inhibitors in the Hamster Flank Organ and Ear11The research has been supported by Endorecherche that is seeking patent protection for the new compounds. F. Labrie is President of Endorecherche.
- In Search of New Therapeutics—Molecular Aspects of the PCOS Pathophysiology: Genetics, Hormones, Metabolism and Beyond
- Skin disease related to metabolic syndrome in women
- Polycystic ovary syndrome (PCOS), an inflammatory, systemic, lifestyle endocrinopathy
- Adult female acne: a guide to clinical practice
- Hirsutism, Normal Androgens and Diagnosis of PCOS
- Clinical biochemistry of dihydrotestosterone
- Risk of Polycystic Ovary Syndrome in Women Exposed to Fine Air Pollutants and Acidic Gases: A Nationwide Cohort Analysis
- Association of single nucleotide polymorphisms in the <i>RAB5B</i> gene 3′UTR region with polycystic ovary syndrome in Chinese Han women
- Are 2D:4D finger-length ratios an indicator of androgenetic alopecia in males?
- Cutaneous manifestation of polycystic ovary syndrome
- Weight Changes Are Linked to Adipose Tissue Genes in Overweight Women with Polycystic Ovary Syndrome
- The Role of Heat Shock Proteins in the Pathogenesis of Polycystic Ovarian Syndrome: A Review of the Literature